CD8A and Alzheimer disease: Importantly, our data from AD patients show an increase in the abundance of intraparenchymal CD103–CD8+ T cells in the hippocampus while the percentage of CD103+CD8+ T cells declines, suggesting CD103– cells may also promote disease development in human AD patients.